About Almirall
Almirall is a publicly listed company based in Barcelona (Spain) founded in 1943. Generic finished formulations are manufactured and commercialized by Almirall. The company has 2,029 employees. Almirall has completed 3 acquisitions, including Aqua Pharm, Poligroupsrl and ThermiGen. Its website almirall.com draws about 36 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Maine Potato Growers, Inc.
Company details
Almirall was founded in 1943 in Barcelona, Spain, and operates within the pharmaceutical sector. Own RD drugs and licensed products are manufactured and commercialized by the company, alongside a portfolio of generic formulations. Strategic brands such as Actikerall, Balneum, Decoderm, Sativex, and Solareze are included in its offerings. Operations focus on drug development and market distribution in Europe and beyond.
- Headquarters Barcelona, Spain
- Employees 2,029
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website almirall.com
- Social LinkedIn X
- Legal Name Almirall Sa
- Annual Revenue$1.3 B (USD)12.41as on Dec 31, 2025
- Net Profit$54.23 M (USD)354.85as on Dec 31, 2025
- EBITDA$257.21 M (USD)18.61as on Dec 31, 2025
- Latest Funding Round$136.38M (USD), Debt – Conventional
Jun 2019
- InvestorsEuropean Investment Bank
& 1 more
- Employee Count2,029
- Investments & AcquisitionsAqua Pharm
& 2 more
Funding Insights of Almirall
- Total Rounds 3
- Last Round Debt – Conventional — $136.38M
- First Round $431,144
(Sep 2015)
- Investors Count 2
All 3 funding rounds of Almirall with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $136.38M | Debt – Conventional | – | – | |
| Jan 2017 | $545,768 | Grant | – | – | |
| Sep 2015 | $431,144 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Almirall
Almirall has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Almirall
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Almirall
349 people are tracked at Almirall (111 in leadership, 11 in board & advisors, 227 in team); the tracked headcount is 2,029.
| Name | Role | Group |
|---|---|---|
Carmen Calvo | VP Global Quality Assurance | Leadership |
Mike McClellan | CFO | Leadership |
Paolo Cionini | Chief Commercial Officer Europe & International | Leadership |
Guenter Schaden | General Manager ACH & Senior Director CEE Countries | Leadership |
Peter Dangel | Executive Director Finance & Group Business Controlling | Leadership |
Nuria Amador | Head Of Europe And North America - Global Partners Markets | Leadership |
David Guinart Carvajal | Senior Director, Global C&b, Labour Relations & People Administration | Leadership |
Joan Francesc Dulsat | Nce´s Late Stage Pharma Development Director | Leadership |
Angels Listán Nicolás | Head Of The CIO Office | Leadership |
Anaïs Moreno | Global People Communication & Change Management Associate Director | Leadership |
Dom Dicindio | Head, US People & Culture | Leadership |
Meritxell Blasco | Global People & Organizational Development Executive Director | Leadership |
Silvia López López | Corporate Finance Manager, Head Of Department | Leadership |
Ester Guiu | Director - Business & Launch Excellence, Global Commercial Operations | Leadership |
Carla Briñardeli Scheibli | People & Culture Business Partner Director | Leadership |
Sophie Rivet | Human Resources Director France | Leadership |
Laure Burtin | Vp, Drug Discovery And Drug Development (molecules) | Leadership |
Lionel Chesnais | Customer Excellence Associate Director | Leadership |
Claudia Soester | Finance Director R&d | Leadership |
Francesc F. | Senior Director R&d Data Science | Leadership |
329 more people are available in the full profile.
Complete people profiles for Almirall
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Almirall
Almirall is a publicly listed company on the BME with ticker symbol ALM in Spain, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Jun 2024
- Listed onBME: ALM
- Listed entityAlmirall SA
- Exchange sectorHealth technology
- ISINES0157097017
- Share price10.14 EUR (+3.15% on the day) · 2026-10-14
- Market capitalisation2,139,866,458.00 EUR
- Price to earnings37.0
- EPS (diluted, trailing year)0.27 EUR
- Dividend yield1.54%
- Volume (last session)43,309
Financials of Almirall
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.11B EUR | 46.1M EUR | 218.9M EUR |
| 2024 | 985.7M EUR | 10.2M EUR | 184.6M EUR |
| 2023 | 894.5M EUR | -38.5M EUR | 164.2M EUR |
| 2022 | 863.2M EUR | 4.3M EUR | 174.2M EUR |
| 2021 | 827.2M EUR | -40.9M EUR | 222.3M EUR |
Detailed financial statements for Almirall
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Almirall
Almirall has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aqua Pharm, Poligroupsrl and ThermiGen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Thermistor-regulated energy systems are developed for aesthetic and dermatology uses. | thermi.com | Austin, United States | 2012 | Jan 2016 | $82M | |
Manufacturer of steerable hydraulic drive axles for agricultural and heavy-duty vehicles | poligroupsrl.com | 0 | Nov 2015 | $386.48M | ||
Specialty pharmaceuticals for dermatological conditions are marketed by Aqua Pharm. | aquapharm.com | West Chester, United States | 2004 | Dec 2013 | $305M |
Complete acquisition details for Almirall
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Almirall
7 dated milestones of Almirall across 81 years, from founding to its latest funding, stage changes and deals.
- Founded Almirall is founded.
- Acquisition Acquires Aqua Pharm.
- Funding First funding round of $431K.
- Acquisition Acquires Poligroupsrl.
- Acquisition Acquires ThermiGen.
- Funding Latest funding round, Debt – Conventional, of $136.4M.
- IPO Lists on the stock exchange (IPO).
Web traffic of Almirall
The website of Almirall (almirall.com) receives about 36.1K visits a month and ranks #950,614 among all websites worldwide, #1,154 in Biotechnology and Pharmaceuticals.
- Monthly visits36.1K
▲ 15.4% vs previous month
- Unique visitors12.6K
per month
- Global rank#950,614
among all websites
- Category rank#1,154
Health · Biotechnology and Pharmaceuticals
- Bounce rate49%
- Pages per visit1.9
- Average visit21 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with Almirall. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
esteve.es | esteve.es | 100% | #1,686,346 | – | |
oindpnews.com | oindpnews.com | 86% | #3,560,291 | – | |
| astrazeneca.com | 79% | 1.3M | #48,983 | View details | |
| pfizer.com | 77% | 1.9M | #24,984 | View details | |
| novartis.com | 75% | 948.8K | #58,822 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 33 similar websites and full traffic analytics for Almirall
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 33 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Almirall
Complete news archive for Almirall
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Almirall
Almirall was founded in 1943 and raised its 1st funding round 72 years after it was founded.
Almirall is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Almirall has 2,029 employees.
Annual revenue of Almirall is $1.3B as on Dec 31, 2025.
Almirall was founded in 1943 in Barcelona, Spain, and operates within the pharmaceutical sector. Own RD drugs and licensed products are manufactured and commercialized by the company, alongside a portfolio of generic formulations. Strategic brands such as Actikerall, Balneum, Decoderm, Sativex, and Solareze are included in its offerings. Operations focus on drug development and market distribution in Europe and beyond.
Yes, Almirall is publicly traded on BME under the ticker symbol ALM.
Almirall has made 3 acquisitions, including Aqua Pharm, Poligroupsrl, and ThermiGen.
Almirall has 2 investors. Key investors include European Investment Bank, and European Union.
Almirall operates through Maine Potato Growers, Inc.